Corporate News     15-Oct-20
AstraZeneca Pharma India to launch Calquence® in India
On 21 October 2020
AstraZeneca Pharma India will launch Calquence® ( Acalabrutinib 100mg capsules) in India on 21 October 2020.

Acalabrutinib100mg capsules (Calquence ®) is:
- indicated for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.
- indicated for treatment of patients with chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL).

Previous News
  Astrazeneca Pharma India standalone net profit rises 167.30% in the June 2023 quarter
 ( Results - Announcements 14-Aug-23   14:37 )
  Astrazeneca Pharma India standalone net profit rises 156.57% in the December 2022 quarter
 ( Results - Announcements 11-Feb-23   07:33 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 08-Aug-19   10:11 )
  Astrazeneca Pharma gains after DCGI nod for cancer drug
 ( Hot Pursuit - 19-Aug-20   12:25 )
  Astrazeneca Pharma India receives DCGI approval to import, market Selumetinib capsules
 ( Hot Pursuit - 27-Sep-21   09:37 )
  AstraZeneca slumps on recording dismal Q1 performance
 ( Hot Pursuit - 08-Aug-24   16:08 )
  Volumes spurt at Godrej Industries Ltd counter
 ( Hot Pursuit - 27-May-22   14:30 )
  Astrazeneca Pharma India standalone net profit declines 45.75% in the December 2021 quarter
 ( Results - Announcements 09-Feb-22   08:13 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 10-Aug-20   16:20 )
  Astrazeneca Pharma India standalone net profit rises 10.17% in the June 2018 quarter
 ( Results - Announcements 15-Aug-18   13:44 )
  Volumes jump at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 12-Sep-22   14:30 )
Other Stories
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
  Blueblood Ventures schedules board meeting
  01-Oct-24   17:39
  CRISIL to discuss results
  01-Oct-24   17:39
  Indian Renewable Energy Deve. Agency to convene board meeting
  01-Oct-24   17:39
  Ashapuri Gold Ornament schedules board meeting
  01-Oct-24   17:38
  Bijoy Hans to conduct board meeting
  01-Oct-24   17:38
  RS Software (India) to announce Quarterly Result
  01-Oct-24   17:38
Back Top